Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Conservation analysis of dengue virus T-cell epitope-based vaccine candidates using Peptide block entropy.

Olsen LR, Zhang GL, Keskin DB, Reinherz EL, Brusic V.

Front Immunol. 2011 Dec 20;2:69. doi: 10.3389/fimmu.2011.00069. eCollection 2011.

2.

A computational approach for identification of epitopes in dengue virus envelope protein: a step towards designing a universal dengue vaccine targeting endemic regions.

Chakraborty S, Chakravorty R, Ahmed M, Rahman A, Waise TM, Hassan F, Rahman M, Shamsuzzaman S.

In Silico Biol. 2010;10(5-6):235-46. doi: 10.3233/ISB-2010-0435.

PMID:
22430357
3.

The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes.

Weiskopf D, Angelo MA, Bangs DJ, Sidney J, Paul S, Peters B, de Silva AD, Lindow JC, Diehl SA, Whitehead S, Durbin A, Kirkpatrick B, Sette A.

J Virol. 2015 Jan;89(1):120-8. doi: 10.1128/JVI.02129-14. Epub 2014 Oct 15.

4.

Identification of cytotoxic T lymphocyte epitopes in dengue virus serotype 1.

Duan Z, Guo J, Huang X, Liu H, Chen X, Jiang M, Wen J.

J Med Virol. 2015 Jul;87(7):1077-89. doi: 10.1002/jmv.24167. Epub 2015 Mar 16.

PMID:
25777343
5.

Conservation and diversity of influenza A H1N1 HLA-restricted T cell epitope candidates for epitope-based vaccines.

Tan PT, Heiny AT, Miotto O, Salmon J, Marques ET, Lemonnier F, August JT.

PLoS One. 2010 Jan 18;5(1):e8754. doi: 10.1371/journal.pone.0008754.

6.

Adenovirus-based vaccines generate cytotoxic T lymphocytes to epitopes of NS1 from dengue virus that are present in all major serotypes.

Gao G, Wang Q, Dai Z, Calcedo R, Sun X, Li G, Wilson JM.

Hum Gene Ther. 2008 Sep;19(9):927-36. doi: 10.1089/hum.2008.011.

PMID:
18788905
7.

Large-scale analysis of antigenic diversity of T-cell epitopes in dengue virus.

Khan AM, Heiny AT, Lee KX, Srinivasan KN, Tan TW, August JT, Brusic V.

BMC Bioinformatics. 2006 Dec 18;7 Suppl 5:S4.

8.

Identification of conserved and HLA-A*2402-restricted epitopes in Dengue virus serotype 2.

Duan ZL, Liu HF, Huang X, Wang SN, Yang JL, Chen XY, Li DZ, Zhong XZ, Chen BK, Wen JS.

Virus Res. 2015 Jan 22;196:5-12. doi: 10.1016/j.virusres.2014.10.022. Epub 2014 Nov 1.

PMID:
25449574
9.

Distinct activation phenotype of a highly conserved novel HLA-B57-restricted epitope during dengue virus infection.

Townsley E, Woda M, Thomas SJ, Kalayanarooj S, Gibbons RV, Nisalak A, Srikiatkhachorn A, Green S, Stephens HA, Rothman AL, Mathew A.

Immunology. 2014 Jan;141(1):27-38. doi: 10.1111/imm.12161.

10.

Superior control of HIV-1 replication by CD8+ T cells targeting conserved epitopes: implications for HIV vaccine design.

Kunwar P, Hawkins N, Dinges WL, Liu Y, Gabriel EE, Swan DA, Stevens CE, Maenza J, Collier AC, Mullins JI, Hertz T, Yu X, Horton H.

PLoS One. 2013 May 31;8(5):e64405. doi: 10.1371/journal.pone.0064405. Print 2013.

11.

Immuno-informatics based approaches to identify CD8+ T cell epitopes within the Leishmania donovani 3-ectonucleotidase in cured visceral leishmaniasis subjects.

Vijayamahantesh, Amit A, Dikhit MR, Singh AK, Venkateshwaran T, Das VNR, Das P, Bimal S.

Microbes Infect. 2017 Apr 1. pii: S1286-4579(17)30040-0. doi: 10.1016/j.micinf.2017.03.002. [Epub ahead of print]

PMID:
28373107
12.

Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.

Dobaño C, Doolan DL.

Mol Immunol. 2007 Apr;44(11):3037-48. Epub 2007 Feb 15.

PMID:
17303242
13.

Immunogenicity of novel Dengue virus epitopes identified by bioinformatic analysis.

Sánchez-Burgos G, Ramos-Castañeda J, Cedillo-Rivera R, Dumonteil E.

Virus Res. 2010 Oct;153(1):113-20. doi: 10.1016/j.virusres.2010.07.014. Epub 2010 Jul 16.

PMID:
20638434
14.

Conservation and variability of dengue virus proteins: implications for vaccine design.

Khan AM, Miotto O, Nascimento EJ, Srinivasan KN, Heiny AT, Zhang GL, Marques ET, Tan TW, Brusic V, Salmon J, August JT.

PLoS Negl Trop Dis. 2008 Aug 13;2(8):e272. doi: 10.1371/journal.pntd.0000272.

15.

Analysis of the DosR regulon genes to select cytotoxic T lymphocyte epitope specific vaccine candidates using a reverse vaccinology approach.

Pandey K, Sharma M, Saarav I, Singh S, Dutta P, Bhardwaj A, Sharma S.

Int J Mycobacteriol. 2016 Mar;5(1):34-43. doi: 10.1016/j.ijmyco.2015.10.005. Epub 2015 Nov 16.

16.

Computational prediction of immunodominant antigenic regions & potential protective epitopes for dengue vaccination.

Muthusamy K, Gopinath K, Nandhini D.

Indian J Med Res. 2016 Oct;144(4):587-591. doi: 10.4103/0971-5916.200894.

17.

Broad and cross-clade CD4+ T-cell responses elicited by a DNA vaccine encoding highly conserved and promiscuous HIV-1 M-group consensus peptides.

Almeida RR, Rosa DS, Ribeiro SP, Santana VC, Kallás EG, Sidney J, Sette A, Kalil J, Cunha-Neto E.

PLoS One. 2012;7(9):e45267. doi: 10.1371/journal.pone.0045267. Epub 2012 Sep 18.

18.

Identification of serotype-specific T cell responses to highly conserved regions of the dengue viruses.

Malavige GN, McGowan S, Atukorale V, Salimi M, Peelawatta M, Fernando N, Jayaratne SD, Ogg G.

Clin Exp Immunol. 2012 May;168(2):215-23. doi: 10.1111/j.1365-2249.2012.04566.x.

19.

A bioinformatics tool for epitope-based vaccine design that accounts for human ethnic diversity: application to emerging infectious diseases.

Oyarzun P, Ellis JJ, Gonzalez-Galarza FF, Jones AR, Middleton D, Boden M, Kobe B.

Vaccine. 2015 Mar 3;33(10):1267-73. doi: 10.1016/j.vaccine.2015.01.040. Epub 2015 Jan 25.

PMID:
25629524
20.

Evaluation of peptide selection approaches for epitope-based vaccine design.

Schubert B, Lund O, Nielsen M.

Tissue Antigens. 2013 Oct;82(4):243-51. doi: 10.1111/tan.12199.

PMID:
24461003

Supplemental Content

Support Center